EHTH eHealth, Inc.

Nasdaq ehealthinsurance.com


$ 4.14 $ 0.08 (1.97 %)    

Tuesday, 11-Nov-2025 15:59:53 EST
QQQ $ 622.05 $ 0.90 (0.15 %)
DIA $ 479.50 $ 5.34 (1.13 %)
SPY $ 683.07 $ 2.90 (0.43 %)
TLT $ 89.88 $ 0.01 (0.01 %)
GLD $ 380.95 $ -0.09 (-0.02 %)
$ 4.14
$ 3.99
$ 4.14 x 60
$ 4.45 x 1
$ 3.99 - $ 4.29
$ 3.18 - $ 11.36
249,606
na
127.37M
$ 1.62
$ 94.28
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-07-2025 03-31-2025 10-Q
4 02-27-2025 12-31-2024 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-29-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-01-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-08-2022 06-30-2022 10-Q
15 05-06-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-08-2021 09-30-2021 10-Q
18 08-06-2021 06-30-2021 10-Q
19 05-10-2021 03-31-2021 10-Q
20 02-26-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-11-2020 03-31-2020 10-Q
24 03-02-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-07-2019 03-31-2019 10-Q
28 03-14-2019 12-31-2018 10-K
29 11-06-2018 09-30-2018 10-Q
30 08-07-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 03-19-2018 12-31-2017 10-K
33 11-07-2017 09-30-2017 10-Q
34 08-07-2017 06-30-2017 10-Q
35 05-05-2017 03-31-2017 10-Q
36 03-16-2017 12-31-2016 10-K
37 11-08-2016 09-30-2016 10-Q
38 08-08-2016 06-30-2016 10-Q
39 05-09-2016 03-31-2016 10-Q
40 03-14-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ehealth-affirms-fy2025-sales-guidance-of-525000m-565000m-vs-547417m-est

eHealth (NASDAQ:EHTH) affirms FY2025 sales outlook from $525.000 million-$565.000 million to $525.000 million-$565.000 million ...

 ehealth-q3-eps-146-beats-164-estimate-sales-53869m-beat-52121m-estimate

eHealth (NASDAQ:EHTH) reported quarterly losses of $(1.46) per share which beat the analyst consensus estimate of $(1.64) by 10...

 an-overview-of-ehealths-earnings
An Overview of eHealth's Earnings
11/04/2025 20:03:42

 ubs-maintains-neutral-on-ehealth-lowers-price-target-to-5

UBS analyst Jonathan Yong maintains eHealth (NASDAQ:EHTH) with a Neutral and lowers the price target from $7 to $5.

 ehealth-raises-fy2025-sales-guidance-from-510000m-550000m-to-525000m-565000m-vs-531555m-est

eHealth (NASDAQ:EHTH) raises FY2025 sales outlook from $510.000 million-$550.000 million to $525.000 million-$565.000 million v...

 ehealth-q2-eps-098-beats-127-estimate-sales-60782m-beat-46506m-estimate

eHealth (NASDAQ:EHTH) reported quarterly losses of $(0.98) per share which beat the analyst consensus estimate of $(1.27) by 22...

Core News & Articles

https://www.wsj.com/health/healthcare/medicare-part-d-drug-plan-premiums-set-to-rise-16ef919c

Core News & Articles

https://www.bloomberg.com/news/articles/2025-06-16/senate-republicans-to-omit-medicare-advantage-cuts-in-tax-bill?embedded-chec...

Core News & Articles

https://www.bloomberg.com/news/articles/2025-06-05/medicare-surfaces-as-target-for-cuts-to-pay-for-trump-tax-bill?srnd=phx-poli...

Core News & Articles

https://www.bloomberg.com/news/articles/2025-06-05/medicare-surfaces-as-target-for-cuts-to-pay-for-trump-tax-bill?srnd=phx-poli...

Core News & Articles

CMS Rolls Out Aggressive Strategy to Enhance and Accelerate Medicare Advantage Audits

 rbc-capital-reiterates-sector-perform-on-ehealth-maintains-11-price-target

RBC Capital analyst Ben Hendrix reiterates eHealth (NASDAQ:EHTH) with a Sector Perform and maintains $11 price target.

 ubs-maintains-neutral-on-ehealth-lowers-price-target-to-7

UBS analyst Jonathan Yong maintains eHealth (NASDAQ:EHTH) with a Neutral and lowers the price target from $9.5 to $7.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION